Sofia, S.N. et al. 2025. Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional class of patients with pulmonary hypertension: A randomized, double-blind, placebo-controlled trial. Narra J. 5, 1 (Jan. 2025), e1301. DOI:https://doi.org/10.52225/narra.v5i1.1301.